Delta4

💡We are moving our main activity to #Bluesky, so follow us there to stay updated on Delta4's developments! bsky.app/profile/delta4ai.bs…

#DISCOVERME has officially launched! A #HorizonEurope project dedicated to #MECFS brings together 20 international partner institutions & leading experts in ME/CFS and Post-Acute Infection Syndromes (#PAIS). One of the goals: pave the way for targeted treatment strategies.

🧠In our joint work with @ConceptLSGroup, we will be hosting a webinar on September 30th where we’ll explore how computation and biology can unlock new targets in neuroinflammation. Register here: 👉insidescientific.com/webinar…

May 12 is #ME/#CFS Awareness Day—a moment to highlight the urgent need for research, recognition, and resources to tackle this complex and debilitating condition. Affecting millions worldwide, it remains one of the most challenging chronic illnesses to diagnose and treat.

Can an AI-identified drug duo change the game for FSGS? 💊 Saroglitazar + Myristic Acid showed strong synergy in preclinical models—tackling fibrosis, inflammation & more. A promising step for rare kidney disease patients. #FSGS #AIinBiotech #DrugRepurposing #RareDisease

💡 Did you know AI can help accelerate the search for new treatments? Learn more about how we’re driving innovation in drug discovery! Visit our blog! delta4.ai/generative-ai/ #AI #Healthcare #Delta4

Join us in Liverpool on April 30th!🧠 Our recent collaboration with @ConceptLSGroup will be presented as a poster at the #BNA2025 Festival of Neuroscience: 📍 Poster Number: PW_064 Stop by to chat about astrocyte biology, neuroinflammation, and computational approaches.

🌸May the Easter Festivities bring renewal, hope, health and much joy to you and your loved ones! #Delta4 #HappyEaster2025

April is #IBSAwarenessMonth 🧠 IBS isn't just a "tummy issue"—it's a neuro-immunological disorder linked to gut dysbiosis, chronic inflammation, and even conditions like endometriosis. Let's raise awareness, push for better diagnostics, and support those affected. #GutHealth

With Hyper-C, Delta4’s proprietary AI platform, we leverage big data to refine molecular models and match compounds to diseases faster and more effectively. 🧠✨Hyper-C provides actionable insights and clear hypotheses—redefining drug discovery. 💊🌟 delta4.ai/hyper-c/

🚨 Fully funded #PhD opportunity in Prostate Cancer Research! Join the EU #PROMOTE #MSCA network & work on precision oncology. 📍 Germany | ⏳ Apply by April 30 🔗euraxess.ec.europa.eu/jobs/3… #JobAlert #MedEd #ScienceJobs @VacancyEdu @PharmiWebJobs

🧠 On #WorldParkinsonsDay, we stand with patients, families & researchers—working toward earlier diagnosis & better care. At Delta4, we apply CNS-focused drug repurposing to tackle unmet needs in brain health. #DrugRepurposing #CNS #Neurodegeneration

Thrilled to welcome two new minds to #TeamDelta4! Peter joined us in mid January, and Louiza just came on board as a PhD within our EU-funded project. Exciting times ahead! 🚀🧪 #DrugRepurposing #Biotech #PhD #EUresearch #LifeSciences

🌟 Rare diseases affect millions worldwide, yet treatment options remain limited. Delta4 is using AI-driven solutions to repurpose existing drugs and develop personalized therapies. 💊 Learn more about our work: delta4.ai/generative-ai/ #AI #Pharma #Delta4

This World Health Day, we celebrate strength and resilience that define true health. At Delta4, we stand with those who face health struggles, offering support and hope on their journey toward well-being. Together, we make health a testament to perseverance. 🌎🩺 #Delta4

🚀 BIO-Europe Spring was a milestone event for us! What stood out? A clear shift: AI in biopharma is no longer a curiosity—it’s a must-have. We’re thrilled to see the industry catching up with the innovation we’ve been driving for years. 💡 Read more here: lnkd.in/dzgvU8-3